Synopsis

Source of validity: Scientific
Rating (out of 5): 3

Bifidobacterium bifidum is one of several probiotic species studied for its potential benefits in managing colitis, particularly inflammatory bowel diseases (IBD) such as ulcerative colitis and Crohn’s disease. Scientific evidence is moderate (rating: 3 out of 5) and primarily comes from preclinical studies, small clinical trials, and meta-analyses of probiotic mixtures rather than B. bifidum alone. Mechanistically, B. bifidum may help by modulating the immune response, strengthening the intestinal barrier, and outcompeting pathogenic bacteria. Some animal studies show that B. bifidum can reduce inflammation and improve histological markers of colitis. In humans, randomized controlled trials using multi-strain probiotic formulations (like VSL#3, which contains B. bifidum among others) have shown benefits in maintaining remission in ulcerative colitis and reducing symptoms, although the specific contribution of B. bifidum is unclear.

Despite these promising results, large-scale, well-controlled trials using B. bifidum as a monotherapy in colitis are lacking. Most evidence supports its use as part of a broader probiotic strategy rather than as a standalone treatment. The overall safety profile is favorable, but guidelines generally recommend probiotics as adjuncts rather than replacements for standard therapy. In summary, while Bifidobacterium bifidum is scientifically validated to some extent for supporting colitis management, especially as part of multi-strain probiotics, the evidence is not robust enough for unequivocal endorsement.

More about bifidobacterium bifidum
More about Colitis

Other ingredients used for Colitis

Other health conditions supported by bifidobacterium bifidum

Products containing bifidobacterium bifidum

Nature's Sunshine Eleven Elevated (NutriBiome)
Nature's Sunshine Probiotic Eleven
Nature's Sunshine Sunshine Heroes Probiotic Power